Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent meningococcal polysaccharide vaccine Phase III trial in ≥2-year-olds
CTR20150352Phase 3Completed
- Sponsor
- Zhejiang Weixin Biopharmaceutical
- Start
- Jun 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of quadrivalent meningococcal polysaccharide vaccine in meningococcal disease, meningococcal meningitis, sponsored by Zhejiang Weixin Biopharmaceutical. Started Jun 2015; status: completed.
02
Drugs
quadrivalent meningococcal polysaccharide vaccine
03
Conditions
meningococcal diseasemeningococcal meningitis
Beyond the preview
Go deeper on CTR20150352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150352.